BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35764946)

  • 1. Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts.
    Wang H; Wang X; Xu L; Zhang J
    BMC Pediatr; 2022 Jun; 22(1):376. PubMed ID: 35764946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets.
    Wang H; Wang X; Xu L; Zhang J; Cao H
    BMC Pediatr; 2020 Jun; 20(1):314. PubMed ID: 32593299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma.
    Wang H; Wang X; Xu L; Zhang J; Cao H
    BMC Pediatr; 2021 Jun; 21(1):272. PubMed ID: 34116676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines.
    Aygun N; Altungoz O
    Mol Med Rep; 2019 Jan; 19(1):345-361. PubMed ID: 30483774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F3 gene expression is a potential negative prognostic marker for localised and MYCN not-amplified neuroblastoma: Results of in silico analysis of 786 samples.
    Ognibene M; Cangelosi D; Sorrentino S; Zanardi S; Zara F; Pezzolo A; Parodi S
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29800. PubMed ID: 35652628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F proteins regulate MYCN expression in neuroblastomas.
    Strieder V; Lutz W
    J Biol Chem; 2003 Jan; 278(5):2983-9. PubMed ID: 12438307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression profiles and prognostic value of E2F family members in clear cell renal cell carcinoma.
    Kim YS; Jung J; Jeong H; Oh HE; Lee JH; Lee ES; Choi JW
    Pathol Res Pract; 2020 Apr; 216(4):152880. PubMed ID: 32089412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of
    Manicum T; Ni F; Ye Y; Fan X; Chen BC
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30487158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
    Gao Z; Shi R; Yuan K; Wang Y
    Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.
    Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S
    Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 1p36 candidate gene ZNF436 predicts the prognosis of neuroblastoma: a bioinformatic analysis.
    Wang H; Wang X; Xu L
    Ital J Pediatr; 2023 Oct; 49(1):145. PubMed ID: 37904225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor compensation during mammary gland development in E2F knockout mice.
    To B; Andrechek ER
    PLoS One; 2018; 13(4):e0194937. PubMed ID: 29617434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.
    Han R; Zhao J; Lu L
    Oncol Rep; 2020 Jun; 43(6):2062-2072. PubMed ID: 32186770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctions in the specificity of E2F function revealed by gene expression signatures.
    Black EP; Hallstrom T; Dressman HK; West M; Nevins JR
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15948-53. PubMed ID: 16249342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Division and apoptosis of E2f-deficient retinal progenitors.
    Chen D; Pacal M; Wenzel P; Knoepfler PS; Leone G; Bremner R
    Nature; 2009 Dec; 462(7275):925-9. PubMed ID: 20016601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.
    Kramps C; Strieder V; Sapetschnig A; Suske G; Lutz W
    J Biol Chem; 2004 Feb; 279(7):5110-7. PubMed ID: 14645238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensation and specificity of function within the E2F family.
    Kong LJ; Chang JT; Bild AH; Nevins JR
    Oncogene; 2007 Jan; 26(3):321-7. PubMed ID: 16909124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNK activation is regulated by E2F and promotes E2F1-induced apoptosis.
    Bashari D; Hacohen D; Ginsberg D
    Cell Signal; 2011 Jan; 23(1):65-70. PubMed ID: 20800677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop.
    Timmers C; Sharma N; Opavsky R; Maiti B; Wu L; Wu J; Orringer D; Trikha P; Saavedra HI; Leone G
    Mol Cell Biol; 2007 Jan; 27(1):65-78. PubMed ID: 17167174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3.
    Chen D; Chen Y; Forrest D; Bremner R
    Cell Death Differ; 2013 Jul; 20(7):931-40. PubMed ID: 23558950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.